U.S. markets closed
  • S&P Futures

    3,249.00
    +11.00 (+0.34%)
     
  • Dow Futures

    26,803.00
    +88.00 (+0.33%)
     
  • Nasdaq Futures

    10,934.25
    +42.50 (+0.39%)
     
  • Russell 2000 Futures

    1,456.30
    +9.30 (+0.64%)
     
  • Crude Oil

    40.26
    -0.05 (-0.12%)
     
  • Gold

    1,869.00
    -7.90 (-0.42%)
     
  • Silver

    23.16
    -0.04 (-0.16%)
     
  • EUR/USD

    1.1671
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    0.6660
    -0.0100 (-1.48%)
     
  • Vix

    28.51
    -0.07 (-0.24%)
     
  • GBP/USD

    1.2754
    +0.0002 (+0.01%)
     
  • USD/JPY

    105.4650
    +0.0630 (+0.06%)
     
  • BTC-USD

    10,736.38
    -24.21 (-0.22%)
     
  • CMC Crypto 200

    227.63
    +18.69 (+8.94%)
     
  • FTSE 100

    5,822.78
    -76.48 (-1.30%)
     
  • Nikkei 225

    23,198.41
    +110.59 (+0.48%)
     

Are Options Traders Betting on a Big Move in Wave Life Sciences (WVE) Stock?

Zacks Equity Research

Investors in Wave Life Sciences Ltd. WVE need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 17, 2020 $20.00 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?   

Clearly, options traders are pricing in a big move for Wave Life Sciences shares, but what is the fundamental picture for the company? Currently, Wave Life Sciences is a Zacks Rank #3 (Hold) in the Medical – Biomedical and Genetics industry that ranks in Top 20% of our Zacks Industry Rank. Over the last 60 days, three analysts have increased their earnings estimates for the current quarter, while none have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from a loss of $1.11 per share to a loss of $1.03 in that period.

Given the way analysts feel about Wave Life Sciences right now, this huge implied volatility could mean there’s a trade developing. Often times, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Looking to Trade Options?
   
Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.

Click to see the trades now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
WAVE Life Sciences Ltd. (WVE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.